WA AND QLD RSV IMMUNISATION PROGRAMS SHOW SIGNIFICANT REDUCTION IN INFANT HOSPITALISATIONS Consumer and HCP awareness, advocacy focus until national program decision is reversed
Filmed Perth, Western Australia | October 2024
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
Associate Professor Hannah Moore OAM, Program Head of Infections and Vaccines at the Kids Research Institute Australia, met with Australian Health Journal to discuss the impact of Respiratory Syncytial Virus (RSV) on children and immunisation showing evidence of a significant reduction in hospitalisations.
She talks about RSV causing chest infections in babies and adults, with most children being infected by the age of three. However, certain groups face higher disease rates, and infants under six months are particularly vulnerable, with up to one in 30 being hospitalised. Even older children up to five years old experience hospitalisation rates for RSV around one in 500 children.
Australian Health Journal also spoke with Catherine Hughes, the Founder and Executive Director of the Immunisation Foundation of Australia (IFA), on the need for RSV immunisations to be included in the National Immunisation Plan to ensure equitable access for vulnerable Australians. RSV immunisation programs in Western Australia and Queensland are showing promising results, leading to a significant reduction in hospitalisations. This is in contrast with the disappointment in the PBAC recently rejecting a national RSV vaccine push.
“Australia urgently needs a nationwide RSV immunisation program,” said Catherine Hughes AM, Founder and Director of the Immunisation Foundation of Australia.
IFA aims to raise awareness of RSV severity and has launched the “Unite Against RSV” campaign to provide resources for the clinical community and families. Additionally, vaccines for adults over 60 and pregnant women, as well as antibody therapy for infants, have been approved to combat RSV. The Foundation also provides regular updates on policy changes related to RSV to clinicians and other providers through its website and email subscriptions.
Efforts are being made to ensure that all Australians, especially vulnerable individuals, have access to affordable RSV immunisations. The Foundation’s advocacy work aims to include RSV immunisations on the National Immunisation Plan to guarantee easy access for all Australian families. The success of RSV immunisation programs in Western Australia and Queensland mounts the evidence on the positive impact of proactive measures in combating RSV.
-
Career advice from an Emergency Physician in Research
Associate Professor Viet Tran, an experienced emergency physician at the Royal Hobart Hospital. He spoke with Australian Health Journal about the crucial role of emergency departments as the frontline of hospitals, providing immediate care, diagnosis, resuscitation, and serving as a safety net for the healthcare system. Prof. Tran highlights the importance of understanding the daily responsibilities and core aspects of a specialty when choosing a medical career.
-
HEALTH CARE BRIEF: Type 1 Diabetes (T1D)
Type 1 Diabetes – Incidence rates, management, lived experience & research
-
Strategic research investments for health and prosperity
The CEO of Research Australia, Nadia Levin spoke with Australian Health Journal about the following:
– Current medical research and development landscape in Australia
– Investment required to support the Health and Medical Research and Innovation pipeline
– The National Medical Products Industry Plan and its impact on the Australian economy
– The Health and Medical Research WorkforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
